BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18638656)

  • 1. Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.
    Ytting H; Christensen IJ; Thiel S; Jensenius JC; Nielsen HJ
    Hum Immunol; 2008 Jul; 69(7):414-20. PubMed ID: 18638656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality.
    Ytting H; Christensen IJ; Thiel S; Jensenius JC; Nielsen HJ
    Clin Cancer Res; 2005 Feb; 11(4):1441-6. PubMed ID: 15746044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer.
    Ytting H; Christensen IJ; Steffensen R; Alsner J; Thiel S; Jensenius JC; Hansen U; Nielsen HJ
    Scand J Immunol; 2011 Feb; 73(2):122-7. PubMed ID: 21198752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mannan-binding lectin and MBL-associated serine protease-2].
    Jørgensen J; Ytting H; Steffensen RM; Nielsen HJ
    Ugeskr Laeger; 2008 Apr; 170(17):1445-8. PubMed ID: 18462622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2).
    Zehnder A; Fisch U; Hirt A; Niggli FK; Simon A; Ozsahin H; Schlapbach LJ; Ammann RA
    Pediatr Blood Cancer; 2009 Jul; 53(1):53-7. PubMed ID: 19343776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer.
    Ytting H; Jensenius JC; Christensen IJ; Thiel S; Nielsen HJ
    Scand J Gastroenterol; 2004 Jul; 39(7):674-9. PubMed ID: 15370690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
    Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
    Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise.
    Ytting H; Christensen IJ; Thiel S; Jensenius JC; Svendsen MN; Nielsen L; Lottenburger T; Nielsen HJ
    Scand J Immunol; 2007 Oct; 66(4):458-64. PubMed ID: 17850591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
    Holten-Andersen MN; Nielsen HJ; Sørensen S; Jensen V; Brünner N; Christensen IJ
    Eur J Cancer; 2006 Aug; 42(12):1889-96. PubMed ID: 16809030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
    Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels.
    Ma CJ; Hsieh JS; Wang WM; Su YC; Huang CJ; Huang TJ; Wang JY
    Kaohsiung J Med Sci; 2006 Dec; 22(12):604-9. PubMed ID: 17116621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
    Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
    Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients.
    Hjelmesaeth J; Ueland T; Flyvbjerg A; Bollerslev J; Leivestad T; Jenssen T; Hansen TK; Thiel S; Sagedal S; Røislien J; Hartmann A
    J Am Soc Nephrol; 2006 Jun; 17(6):1746-54. PubMed ID: 16687626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease 2 in endemic pemphigus foliaceus.
    Messias-Reason I; Bosco DG; Nisihara RM; Jakobsen LH; Petzl-Erler ML; Jensenius JC
    Clin Exp Dermatol; 2008 Jul; 33(4):495-7. PubMed ID: 18498410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity.
    Sorensen GL; Petersen I; Thiel S; Fenger M; Christensen K; Kyvik KO; Sørensen TI; Holmskov U; Jensenius JC
    Genet Epidemiol; 2007 Jan; 31(1):31-41. PubMed ID: 17096357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.